肝病中的骨质疏松症：发病机制与管理
Osteoporosis in liver disease: pathogenesis and management.
作者信息
Handzlik-Orlik Gabriela, Holecki Michał, Wilczyński Krzysztof, Duława Jan
机构信息
Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, ul. Ziołowa 45/47, 40-635 Katowice, Poland.
Department of Internal Medicine and Metabolic Diseases, School of Health Science, Medical University of Silesia, Katowice, Poland.
出版信息
Ther Adv Endocrinol Metab. 2016 Jun;7(3):128-35. doi: 10.1177/2042018816641351. Epub 2016 Apr 6.
Abstract
Osteoporosis affects a substantial proportion of patients with chronic liver disease. Pathologic fracture in osteoporosis significantly affects quality of life and life expectancy. By some estimates, 40% of patients with chronic liver disease may experience osteoporotic fracture. In this study we review the pathogenesis, diagnosis and treatment of specific liver disease entities and their relation to osteoporosis.
摘要
骨质疏松症影响着相当一部分慢性肝病患者。骨质疏松症中的病理性骨折会显著影响生活质量和预期寿命。据一些估计，40%的慢性肝病患者可能会发生骨质疏松性骨折。在本研究中，我们回顾了特定肝病实体的发病机制、诊断和治疗及其与骨质疏松症的关系。
相似文献
1
Osteoporosis in liver disease: pathogenesis and management.肝病中的骨质疏松症：发病机制与管理
Ther Adv Endocrinol Metab. 2016 Jun;7(3):128-35. doi: 10.1177/2042018816641351. Epub 2016 Apr 6.
2
Osteoporosis in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者的骨质疏松症。
Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1397-401. doi: 10.1097/MEG.0b013e3283405939.
3
Osteoporosis across chronic liver disease.慢性肝病中的骨质疏松症。
Osteoporos Int. 2016 Jun;27(6):1967-77. doi: 10.1007/s00198-016-3512-z. Epub 2016 Feb 4.
4
Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.骨折风险计算工具改善了肝硬化患者的双能X线吸收测定扫描转诊流程。
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):757-61. doi: 10.1097/MEG.0000000000000585.
5
Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.非酒精性脂肪性肝炎患者中铁代谢紊乱基因突变的患病率及其与肝纤维化程度的相关性
Arq Gastroenterol. 2006 Jul-Sep;43(3):224-8. doi: 10.1590/s0004-28032006000300013.
6
Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.非酒精性脂肪性肝病与骨质疏松症：一项系统综述和荟萃分析
J Bone Miner Metab. 2017 Nov;35(6):685-693. doi: 10.1007/s00774-016-0807-2. Epub 2016 Dec 7.
7
8
Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.法国初级医疗保健中绝经后骨质疏松症患者的特征分析。
Drugs Aging. 2007;24(7):603-14. doi: 10.2165/00002512-200724070-00007.
9
[Secondary osteoporosis. Bone disease in liver cirrhosis.].[继发性骨质疏松症。肝硬化中的骨病。]
Clin Calcium. 2018;28(12):1659-1664.
10
[Long-term risk of osteoporotic fracture in Belgium].[比利时骨质疏松性骨折的长期风险]
Rev Med Liege. 2008 Jul-Aug;63(7-8):480-7.
引用本文的文献
1
Short-Term Outcomes of Noncemented Total Knee Arthroplasty in Patients With Morbid Obesity.病态肥胖患者非骨水泥全膝关节置换术的短期疗效
J Am Acad Orthop Surg Glob Res Rev. 2025 Mar 3;9(3). doi: 10.5435/JAAOSGlobal-D-24-00299. eCollection 2025 Mar 1.
2
Accelerated aging of skeletal muscle and the immune system in patients with chronic liver disease.慢性肝病患者骨骼肌和免疫系统的加速老化。
Exp Mol Med. 2024 Jul;56(7):1667-1681. doi: 10.1038/s12276-024-01287-y. Epub 2024 Jul 18.
3
How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.年龄、性别和输血如何影响重型地中海贫血患者内分泌及骨密度紊乱的发生率
Iran J Public Health. 2024 Feb;53(2):433-442. doi: 10.18502/ijph.v53i2.14928.
4
High C-reactive protein-to-albumin ratio levels are associated with osteoporosis in patients with primary biliary cholangitis.高 C 反应蛋白-白蛋白比值水平与原发性胆汁性胆管炎患者的骨质疏松症有关。
Front Endocrinol (Lausanne). 2024 May 30;15:1415488. doi: 10.3389/fendo.2024.1415488. eCollection 2024.
5
Bone-organ axes: bidirectional crosstalk.骨-器官轴：双向串扰。
Mil Med Res. 2024 Jun 12;11(1):37. doi: 10.1186/s40779-024-00540-9.
6
From liver to hormones: The endocrine consequences of cirrhosis.从肝脏到激素：肝硬化的内分泌后果。
World J Gastroenterol. 2024 Mar 7;30(9):1073-1095. doi: 10.3748/wjg.v30.i9.1073.
7
Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence.酒精性肝硬化和慢性酒精滥用中骨质恶化的临床指标：超越骨折发生率的研究
Diagnostics (Basel). 2024 Feb 28;14(5):510. doi: 10.3390/diagnostics14050510.
8
Boosting plant food polyphenol concentration by saline eustress as supplement strategies for the prevention of metabolic syndrome: an example of randomized interventional trial in the adult population.通过适度盐胁迫提高植物性食物中的多酚浓度作为预防代谢综合征的补充策略：一项针对成年人群的随机干预试验实例
Front Nutr. 2023 Dec 22;10:1288064. doi: 10.3389/fnut.2023.1288064. eCollection 2023.
9
Evaluation and Management of Chronic Cholestatic Liver Diseases.慢性胆汁淤积性肝病的评估与管理
Middle East J Dig Dis. 2023 Jul;15(3):148-155. doi: 10.34172/mejdd.2023.336. Epub 2023 Jul 30.
10
Metabolic bone disease heralding the diagnosis of Wilson's disease.代谢性骨病预示着威尔逊病的诊断。
BMJ Case Rep. 2023 Jul 25;16(7):e252290. doi: 10.1136/bcr-2022-252290.
本文引用的文献
1
New method for point-of-care osteoporosis screening and diagnostics.即时护理骨质疏松症筛查与诊断的新方法。
Osteoporos Int. 2016 Mar;27(3):971-977. doi: 10.1007/s00198-015-3387-4. Epub 2015 Nov 10.
2
EASL Clinical Practice Guidelines: Autoimmune hepatitis.欧洲肝脏研究学会临床实践指南：自身免疫性肝炎
J Hepatol. 2015 Oct;63(4):971-1004. doi: 10.1016/j.jhep.2015.06.030. Epub 2015 Sep 1.
3
Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.围绝经期女性维生素D3受体多态性及其与骨密度的关系。
Osteoporos Int. 2015 Mar;26(3):1045-52. doi: 10.1007/s00198-014-2947-3. Epub 2014 Nov 19.
4
Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.肝病中的骨质疏松症与骨折：相关性、发病机制及治疗意义
World J Gastroenterol. 2014 Jul 28;20(28):9427-38. doi: 10.3748/wjg.v20.i28.9427.
5
Osteoporosis in primary biliary cirrhosis of the liver.肝原发性胆汁性肝硬化中的骨质疏松症。
Prz Gastroenterol. 2014;9(2):82-7. doi: 10.5114/pg.2014.42502. Epub 2014 May 5.
6
Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies.通过控制营养状况指数进行营养筛查与各种病因慢性肝病患者骨密度之间的关联
Hepatol Res. 2015 Jun;45(6):618-28. doi: 10.1111/hepr.12395. Epub 2014 Aug 19.
7
Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update.波兰骨质疏松症诊断与管理指南：2013年更新版综述
Pol Arch Med Wewn. 2014;124(5):255-63. doi: 10.20452/pamw.2255. Epub 2014 Mar 27.
8
Alcoholic liver disease and changes in bone mineral density.酒精性肝病与骨密度变化
Rev Esp Enferm Dig. 2013 Nov-Dec;105(10):609-21. doi: 10.4321/s1130-01082013001000006.
9
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency.中欧维生素D补充与缺乏症治疗实用指南——一般人群及维生素D缺乏风险人群的维生素D推荐摄入量
Endokrynol Pol. 2013;64(4):319-27. doi: 10.5603/ep.2013.0012.
10
Extrahepatic complications of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的肝外并发症。
Hepatology. 2014 Mar;59(3):1174-97. doi: 10.1002/hep.26717. Epub 2014 Jan 16.
Zotero 插件